10 Best Long Term Stocks to Buy According to Billionaires

2. Eli Lilly and Company (NYSE:LLY)

Number of Billionaire Holders: 23

Eli Lilly and Company (NYSE:LLY) is an Indiana-based multinational pharmaceutical company that offers a wide range of related services and products. The company has become a highly sought-after stock in recent years due to its work with GLP-1-related treatments. The company has two GLP-1-approved drugs, Zepbound (for weight loss) and Mounjaro (for diabetes), and the potential billions in revenue these drugs could bring in the future has led investors to be optimistic about its growth prospects.

In addition to its success with GLP-1 drugs, there’s also excitement around Kisunla, an Alzheimer’s treatment approved by regulators last year, which could become another major revenue driver for the company. Eli Lilly and Company (NYSE:LLY) is also exploring further growth opportunities. For example, last year, the company partnered with Aktis Oncology to develop radiopharmaceuticals, a cutting-edge cancer treatment that targets specific cancer cells. This is just one example of the company’s diverse and promising pipeline.

Eli Lilly and Company (NYSE:LLY) holds a strong dividend policy and currently pays a quarterly dividend of $1.50 per share. The company maintains an 11-year streak of consistent dividend growth. The stock supports a dividend yield of 0.79%, as of April 15.